On July 13, 2026, the European Commission (“Commission”) adopted two new Regulations that will shape the implementation of the EU Deforestation Regulation (Regulation (EU) 2023/1115, “EUDR”). The EUDR will start applying to large and medium-sized operators and traders at the end of this year (i.e., December 30, 2026).

This post provides a high-level overview of the key changes under the two new Regulations, their timelines for formal adoption, and some practical considerations for companies preparing for compliance.

Background and Context for the Measures

By way of background, under the EUDR, economic operators may only place on the EU market, make available in the EU, or export from the EU the specific commodities and products listed in Annex I to the EUDR if three cumulative conditions are met. The products must be:

(i) deforestation free;
(ii) produced in accordance with the relevant legislation of the country of production; and
(iii) covered by a due diligence statement (“DDS”).  

The EUDR establishes a role-based allocation of obligations along the supply chain, varying by the nature of the product, the commercial activity performed, and each actor’s position in the supply chain. 

These new Regulations come after the Commission published a simplification package earlier this year (see press release here), delivering on the Commission’s commitment to the European Parliament and Council of the EU to conduct a simplification review of the EUDR by April 30, 2026 (following the December 2025 Amending Regulation of the EUDR). For more detail, see our blog post on the December 2025 EUDR simplification here.

The first new regulation the Commission has adopted is a Delegated Regulation, which updates and simplifies the list of relevant products covered by Annex I of the EUDR. The Delegated Regulation is now subject to a two-month scrutiny period by the European Parliament and the Council, which is extendable by another two months, and will only enter into force following its publication in the Official Journal of the EU.

The second Regulation is Commission Implementing Regulation (EU) 2026/1565, setting out the functioning of the EUDR Information System used to submit DDSs and simplified declarations under the EUDR. The Implementing Regulation entered into force on July 17, 2026, and is directly applicable in all EU Member States.

Delegated Regulation: Targeted Changes to Products in Scope of EUDR

The Delegated Regulation refines the scope of products subject to due diligence obligations under the EUDR. In particular, it introduces “limited and targeted fixes” to the Annex I list of in-scope products, exercising the Commission’s power to update the list of relevant CN (Combined Nomenclature) codes (i.e., the 8-digit EU system for classification of goods) set out in that Annex.

Key changes introduced in the Delegated Act include:

  • Additions to scope as of December 2027: The Delegated Regulation adds several products to Annex I that will only become subject to the Regulation as of December 30, 2027, giving operators, competent authorities, and customs authorities time to prepare:
    • Frozen cattle tongues, added for coherence given that fresh cattle tongues were already in scope.
    • Soluble coffee (extracts, essences, and concentrates of coffee), closing a gap in the coffee sector where other forms of coffee beans (e.g., roasted or green) were already covered.
    • Additional palm oil oleochemical derivatives, including certain hydrogenated and inter-esterified palm and palm kernel oils, crude glycerol, fatty alcohols, and related fatty acid salts and esters that have been synthesized using palm oil, extending the oleochemicals product pallet already captured under the EUDR. However, crucially, these products are excluded from the EUDR scope where they are used to manufacture human or veterinary medicinal products.
    • Certain soap products (bars, cakes, and other moulded shapes for toilet use, and soap in other forms) that contain or are made using palm oil, a change the Commission justified on coherence and effectiveness grounds across the oleochemicals product range.
  • Removals and narrowing: The Delegated Regulation removes or narrows several product categories, most with immediate effect.
    • Cattle hides, skins, and leather (i.e., raw or preserved hides and skins, tanned or crust hides and skins, and further-prepared leather) are deleted from Annex I. This was among the more contested changes, and the Commission has signaled that the issue will be revisited as part of the general review required under Article 34(2) by June 2030.
    • Vulcanised rubber articles and belts (conveyor and transmission belts, and other articles of vulcanised rubber) are removed given their low natural rubber content and correspondingly limited deforestation impact.
    • Aircraft and motor vehicle seats are carved out of the broad wood-seat category that previously captured them, replaced by a narrower list of wood-seat and wood-parts codes.
    • Soya beans for sowing are excluded from the soybean category, which is narrowed accordingly.
    • Retreaded tires are narrowed so that the due diligence obligation applies only to the new rubber tread applied during retreading, rather than to the retreaded tire as a whole.
    • Live cattle entries are consolidated into a single CN code, a simplification with no substantive change to the product’s scope.

Overall, the revised Annex I draws finer distinctions between products, so whether an item is in scope increasingly turns on its specific 8-digit CN code rather than on the broader product category it sits in. Additionally, in some cases, scope no longer turns on the product’s classification alone: several of the new carve-outs depend instead on how an item is used or supplied, so that an otherwise-covered product – such as packaging, a sample, or accompanying marketing material – may fall outside the Regulation by reason of its function or the purpose for which it is placed on the market. In practice, companies will need to check the precise CN code of each product and, where a carve-out may apply, how it is used or supplied to confirm whether it falls within the EUDR’s scope.

Implementing Regulation on the EUDR Information System

The Commission has also adopted the Implementing Regulation establishing technical rules for the EUDR Information System, pursuant to Article 33(3) of the EUDR. The EUDR Information System is the platform through which EUDR DDSs and simplified declarations are submitted. The Implementing Regulation entered into force on July 17, 2026, and is directly applicable in all EU Member States.

This Regulation updates Implementing Regulation (EU) 2024/3084 to operationalize the new “downstream operator” and “micro or small primary operator” categories introduced by the December 2025 Amending Regulation, which relieved downstream operators and traders of the obligation to submit DDSs and allowed micro and small primary operators to submit a simplified declaration instead of a full DDS.

The Regulation introduces several practical improvements, including:

  • A Simplified Declaration form for micro and small primary operators: Users may submit a Simplified Declaration directly, or, where the required information is already held in a Member State or EU database, Member States may feed that information directly into the Information System on behalf of the operator.
  • A voluntary grouping feature: Users may group multiple previously submitted DDSs or simplified declarations into a single grouped statement by referencing their prior reference numbers or declaration identifiers (for example, to cover a master DDS spanning multiple shipments).
  • Streamlined user registration: Users must register once and may hold multiple roles under a single account in the Information System.

Additional functionalities are expected to be introduced later this summer, and the Commission is separately working with Member States to feed information from national databases directly into the Information System to further reduce the burden on micro and small primary operators.

Taken together, these targeted additions, removals, and clarifications, alongside the platform improvements, are intended to give operators, customs authorities, and competent authorities greater clarity and legal certainty on what falls within scope and what compliance will require ahead of the EUDR’s December 2026 application. With no further postponement planned, companies should consider revisions that may need to be made to compliance programs ahead of this date.

* * *

If you have any questions concerning the material discussed in this post or on the EUDR in general, please contact the members of our team.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Zoé Bertrand Zoé Bertrand

Zoé Bertrand is an associate in the Sustainability and Life Sciences Practice Groups, where her practice covers ESG, sustainability, environmental, food, and pharmaceutical regulation. She has experience in a wide range of regulatory and compliance issues with a focus on EU, Belgian, and…

Zoé Bertrand is an associate in the Sustainability and Life Sciences Practice Groups, where her practice covers ESG, sustainability, environmental, food, and pharmaceutical regulation. She has experience in a wide range of regulatory and compliance issues with a focus on EU, Belgian, and French regulatory advice.

She advises on compliance with EU ESG regulations, encompassing the CSRD, the CSDDD, and the EUDR, covering aspects as scope, timeline, implementation, and enforcement. As part of her practice, Zoé also covers environmental matters including the urban wastewater treatment directive, extended producer responsibility, chemicals regulations, and greenwashing.

Zoé also assists clients with the implementation of the Nagoya Protocol and the access and benefit sharing rules of a number of jurisdictions. Zoé closely follows international developments on biodiversity.

Photo of Hannah Edmonds-Camara Hannah Edmonds-Camara

Hannah Edmonds-Camara is a founding member of the firm’s Business and Human Rights (BHR) practice and advises on a breadth of BHR and ESG issues. In particular, Hannah has deep experience advising on the development and implementation of global human rights and environmental…

Hannah Edmonds-Camara is a founding member of the firm’s Business and Human Rights (BHR) practice and advises on a breadth of BHR and ESG issues. In particular, Hannah has deep experience advising on the development and implementation of global human rights and environmental due diligence programmes, in response to the evolving, global regulatory landscape.

She advises on: compliance with ESG disclosure and due diligence requirements, including the EU’s CSRD and CSDDD; BHR-related investigations and remediation strategies; forced labour import ban regimes (e.g. the EU’s Forced Labour Regulation); responding to complaints raised through non-judicial grievance mechanisms (including OECD National Contact Points); ESG due diligence in an M&A context; global risk assessments; workplace culture reviews; design of project and issue-specific human rights frameworks and stakeholder engagement strategies; and policy engagement on BHR legislative files.

Photo of Daniel Feldman Daniel Feldman

Dan Feldman co-chairs the firm’s ESG and Business & Human Rights practices.

Drawing on his prior positions in government service spanning multiple Administrations, former Ambassador Dan Feldman’s practice focuses on environmental, social, and governance (ESG) counseling, business and human rights (BHR), global public…

Dan Feldman co-chairs the firm’s ESG and Business & Human Rights practices.

Drawing on his prior positions in government service spanning multiple Administrations, former Ambassador Dan Feldman’s practice focuses on environmental, social, and governance (ESG) counseling, business and human rights (BHR), global public policy, as well as broader international regulatory compliance. He is a member of the firm’s Global Problem Solving initiative.

As Chief of Staff and Counselor to Secretary John Kerry when he was appointed the first Special Presidential Envoy for Climate (SPEC) by President Biden, Dan helped drive the U.S. government’s international climate agenda, coordinating high level interagency policy-making, engaging with corporate stakeholders, and contributing to key bilateral and multilateral climate discussions, including the 2021 Leaders’ Summit on Climate and the landmark UN Conference of Parties (COP26) in Glasgow.

Previously, Dan served as deputy and then U.S. Special Representative for Afghanistan and Pakistan at the U.S. Department of State in the Obama Administration, as Director of Multilateral and Humanitarian Affairs at the National Security Council in the Clinton Administration, and as Counsel and Communications Adviser to the U.S. Senate Homeland Security and Governmental Affairs Committee. He also has served as a senior foreign policy and national security advisor to a number of Democratic presidential and Congressional campaigns.

Dan has extensive experience counseling multinational corporations on mitigating risk and maximizing opportunities in the development and implementation of their ESG and sustainability strategies, with a particular background in advising on BHR matters. He was one of the first attorneys in the U.S. to develop a practice in corporate social responsibility, and has been cited by Chambers for his BHR expertise. He assists clients in strategizing about their engagements with a range of key stakeholders, including Members of Congress, executive branch officials, foreign government officials and Embassy representatives, multilateral institutions, trade and industry associations, non-governmental organizations, opinion leaders, and journalists.

Photo of Seán Finan Seán Finan

Seán Finan is an associate in the Life Sciences team. His practice covers environmental, food and beverage and pharmaceutical regulation.

Seán has specific experience in a number of key areas for EU and UK clients in the technology, food and beverage, pharmaceutical, cosmetic…

Seán Finan is an associate in the Life Sciences team. His practice covers environmental, food and beverage and pharmaceutical regulation.

Seán has specific experience in a number of key areas for EU and UK clients in the technology, food and beverage, pharmaceutical, cosmetic and consumer goods industries, including:

Environmental and ESG compliance issues, including CSRD, CSDDD and green taxonomy issues; green public procurement issues; extended producer responsibility obligations, etc.;
Advertising claims, particularly environmental claims and greenwashing;
General food regulation; novel food regulation; genetically modified and “precision bred” products; and
Chemicals legislation (REACH, CLP, biocides, etc.).

Seán has represented clients in judicial review actions involving novel foods against multiple national regulators.

Seán is qualified in both England & Wales, and the Republic of Ireland.

Seán is a co lead of the firm’s Disability and Mental Health affinity group.

Photo of Cándido García Molyneux Cándido García Molyneux

Cándido García Molyneux provides clients with regulatory, policy and strategic advice on EU environmental and product safety legislation. He helps clients influence EU legislation and guidance and comply with requirements in an efficient manner, representing them before the EU Courts and institutions.

Cándido…

Cándido García Molyneux provides clients with regulatory, policy and strategic advice on EU environmental and product safety legislation. He helps clients influence EU legislation and guidance and comply with requirements in an efficient manner, representing them before the EU Courts and institutions.

Cándido co-chairs the firm’s Environmental Practice Group.

Cándido has a deep knowledge of EU requirements on chemicals, circular economy and waste management, climate change, energy efficiency, renewable energies as well as their interrelationship with specific product categories and industries, such as electronics, cosmetics, healthcare products, and more general consumer products. He has worked on energy consumption and energy efficiency requirements of AI models under the EU AI Act.

In addition, Cándido has particular expertise on EU institutional and trade law, and the import of food products into the EU. Cándido also regularly advises clients on Spanish food and drug law.

Cándido is described by Chambers Europe as being “creative and frighteningly smart.” His clients note that “he has a very measured, considered, deliberative manner,” and that “he has superb analytical and writing skills.”

Photo of Elise Hartnett Elise Hartnett

Elise Hartnett advises clients on EU and U.S. regulatory and policy matters across environmental, social, and governance (ESG), business and human rights (BHR), international trade, and public policy.

Her practice includes providing clients with tailored advice on EU sustainability laws, global supply chain…

Elise Hartnett advises clients on EU and U.S. regulatory and policy matters across environmental, social, and governance (ESG), business and human rights (BHR), international trade, and public policy.

Her practice includes providing clients with tailored advice on EU sustainability laws, global supply chain due diligence, human rights and environmental policy development, evolving greenhouse gas and corporate climate action reporting requirements, and navigating compliance risks under EU and international legal obligations.

Elise also maintains an active pro bono practice focused on media freedom, human rights, and access to justice.

Photo of Max Jerman Max Jerman

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native…

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native Italian and Slovenian speaker.

Photo of Lasse Luecke Lasse Luecke

Lasse Luecke advises clients on EU regulatory and policy matters with a focus on environmental, technology, and product safety legislation. He has particular expertise in radio equipment legislation, including radiofrequency spectrum use and availability, data center regulation, and sustainability reporting frameworks, where he…

Lasse Luecke advises clients on EU regulatory and policy matters with a focus on environmental, technology, and product safety legislation. He has particular expertise in radio equipment legislation, including radiofrequency spectrum use and availability, data center regulation, and sustainability reporting frameworks, where he supports companies in meeting complex and rapidly evolving compliance obligations. Lasse also helps clients anticipate legislative developments, shape regulatory strategy, and engage constructively with EU institutions and policymakers.

Photo of Paul Mertenskötter Paul Mertenskötter

Paul Mertenskötter advises companies, investors, and governments on regulatory sustainability, international trade, and public policy matters.

Paul has particular experience advising multinational companies on EU sustainability laws, including the Corporate Sustainability Reporting Directive (CSRD), the Corporate Sustainability Due Diligence Directive (CSDDD), the Taxonomy…

Paul Mertenskötter advises companies, investors, and governments on regulatory sustainability, international trade, and public policy matters.

Paul has particular experience advising multinational companies on EU sustainability laws, including the Corporate Sustainability Reporting Directive (CSRD), the Corporate Sustainability Due Diligence Directive (CSDDD), the Taxonomy Regulation, the Forced Labor Regulation, and the Carbon Border Adjustment Mechanism (CBAM). His practice also spans a wide range of climate change issues, including carbon offsets, accounting rules, and related international sustainability reporting frameworks such as the International Sustainability Standards Board (ISSB). Paul further advises clients on their strategic engagement with the rules of the World Trade Organization (WTO), free trade agreements, the Paris Agreement, and general public international law.

Prior to joining the firm, Paul was a Visiting Scholar at the WTO in Geneva, clerked at the International Court of Justice in The Hague, and was a Fellow at the Institute for International Law and Justice at NYU Law School.

Photo of Mary Mikhaeel Mary Mikhaeel

Mary Mikhaeel advises clients on developing sophisticated human rights compliance programs, based on human rights-focused hard law and international best practices. She works with clients to develop cutting edge solutions to forced labor supply chain risks, and also advises clients on a wide…

Mary Mikhaeel advises clients on developing sophisticated human rights compliance programs, based on human rights-focused hard law and international best practices. She works with clients to develop cutting edge solutions to forced labor supply chain risks, and also advises clients on a wide range of Customs matters.

As a member of Covington’s Business and Human Rights Practice Group, Mary supports companies in furthering their commitment to respecting human rights, as articulated in the UN Guiding Principles on Business and Human Rights (UNGPs). She has experience in assisting companies with building compliance programs, conducting human rights risk assessments and investigations, and developing human rights due diligence procedures.

Mary has extensive experience counseling clients across a wide range of industries on how to mitigate forced labor risks in the context of U.S. anti-forced labor laws, including the Uyghur Forced Labor Prevention Act (UFLPA) and Withhold Release Orders (WROs).

Mary is also a member of Covington’s customs practice and advises clients on a wide range of issues related to customs compliance and tariff mitigation strategies. She has experience advising clients on seeking ruling requests with Customs, assisting clients in submitting prior disclosures, and conducting internal compliance reviews.

Prior to law school, Mary was part of a research team that developed the Corporations and Human Rights Database, the first database created to monitor public allegations of business’ possible human rights violations. She also worked at the University of Minnesota’s Human Rights program on a variety of business and human rights matters, including issues related to a forced displacement case before the Inter-American Commission on Human Rights, and interned for a human rights non-government organization that holds consultative status with the United Nations.

Photo of Tom Plotkin Tom Plotkin

Tom Plotkin advises companies on a broad range of ESG and sustainability issues with a focus on social responsibility, including business and human rights, equity and civil rights, and external engagement and brand reputation.

As a member of Covington’s Business and Human Rights…

Tom Plotkin advises companies on a broad range of ESG and sustainability issues with a focus on social responsibility, including business and human rights, equity and civil rights, and external engagement and brand reputation.

As a member of Covington’s Business and Human Rights practice, Tom advises clients on all aspects of the corporate responsibility to respect human rights, including issues related to supply chain due diligence and responsible sourcing, downstream product use and human rights impacts, and strategies for integrating human rights oversight into broader compliance programs.

Tom is also a member of Covington’s Institutional Culture and Social Responsibility practice, where he assists companies in evaluating and managing the legal, business, and reputational risks associated with social impacts of business practices. Tom’s work in this area focuses on civil rights and diversity, equity, and inclusion.

As a member of Covington’s Sustainability practice, Tom draws on his social responsibility portfolio to assist companies in bridging internal practices and external engagement strategies. Tom assists with public ESG reporting, responding to shareholder ESG proposals, and external stakeholder engagement.

Tom is also a member of Covington’s Employment practice, where he advises on a range of domestic and international employment law issues.

Photo of Emma Sawatzky Emma Sawatzky

Emma Sawatzky advises clients on a range of human rights and sustainability issues and supports them in evaluating and addressing potential legal, operational, and reputational risks across geographies and sectors.

As a member of Covington’s Business and Human Rights and Sustainability Practice Groups…

Emma Sawatzky advises clients on a range of human rights and sustainability issues and supports them in evaluating and addressing potential legal, operational, and reputational risks across geographies and sectors.

As a member of Covington’s Business and Human Rights and Sustainability Practice Groups, Emma advises clients on the rapidly evolving legal and enforcement landscape. Emma has experience with preparing clients for modern slavery and sustainability reporting; conducting gap assessments and developing action plans for sophisticated compliance programs; formulating human rights policies; conducting BHR-related investigations and implementing remediation strategies; advising on human rights-related OECD proceedings; developing responsible sourcing frameworks (including risk assessments, traceability exercises, and supplier engagement strategies); and advising on the potential human rights impacts of downstream product and service use. Emma also assists clients with white collar investigations.

Photo of Pimara Soongswang Pimara Soongswang

Pimmy Soongswang is an associate in the Business and Human Rights (BHR) and Sustainability practice groups. She advises clients on their human rights obligations under international standards and supports them in navigating the evolving legal frameworks surrounding responsible business conduct.

Pimmy works across…

Pimmy Soongswang is an associate in the Business and Human Rights (BHR) and Sustainability practice groups. She advises clients on their human rights obligations under international standards and supports them in navigating the evolving legal frameworks surrounding responsible business conduct.

Pimmy works across a range of BHR-related matters, including global supply chain due diligence, modern slavery reporting, forced labour-related import bans, human rights policy development, and OECD proceedings involving human rights issues. Her practice also includes assessing downstream human rights risks associated with AI and other digital products within the context of developing human rights due diligence frameworks.

Pimmy is engaged in pro bono work focused on the rights of women and underrepresented communities. In addition to her client work, she contributes to the firm’s diversity and inclusion efforts

Photo of Bart Van Vooren Bart Van Vooren

Bart Van Vooren, partner leads a dynamic practice at the intersection of EU regulatory law, global health, and biodiversity law. In these fields, he advises innovative pharmaceutical, food, cosmetic and technology companies on complex EU and global regulatory, compliance and policy assignments.

Bart…

Bart Van Vooren, partner leads a dynamic practice at the intersection of EU regulatory law, global health, and biodiversity law. In these fields, he advises innovative pharmaceutical, food, cosmetic and technology companies on complex EU and global regulatory, compliance and policy assignments.

Bart holds a Ph.D. in EU and International Law and was a professor of EU law until 2013. During that time, he wrote the first-ever handbook with Cambridge University Press on “EU External Relations Law” (2014). He then transitioned to private practice, and frequently acted for the Belgian government before the EU Court of Justice (e.g. C-16/16P Belgium vs Commission). Bart joined Covington in 2016, leading some of our most consequential EU litigation proceedings (e.g. C-311/18 “Schrems II”) over the years.  Having handled nearly 50 cases before the EU Court, he’s uniquely qualified to support our corporate clients in our most high-stakes disputes. Recent examples include T-189/21 Aloe Vera of Europe v Commission (which we won, so the Commission decided to appeal); as well as T-201/21 Covington & Burling and Van Vooren v Commission (which we also won, and hence is also on appeal).

As a pioneer in biodiversity law, over the past 15 years Bart has built a unique, global practice on Access and Benefit-Sharing (ABS) laws under the Convention on Biological Diversity, the Nagoya Protocol, the Plant Treaty, the High Seas Treaty and the WHO Pandemic Agreement. ABS compliance is critical when sourcing biological materials for life sciences R&D and I work with many of the world’s innovative life sciences companies on the whole range of e.g. transactional, contractual, compliance, IP, (EU) regulatory and litigation work relating to ABS. As biodiversity has increasingly become identified as a major commercial and financial risk to companies, so has the practice expanded to e.g. biodiversity credit markets, biodiversity insurance, biodiversity claims and advertising, and so on. Since April 2025, Bart has been appointed as the industry representative to the Steering Committee of the UN Biodiversity Fund that seeks funding from the private sector for biodiversity conservation and restoration.

Bart also pioneered our global health practice. He has advised pharmaceutical clients on seasonal and pandemic influenza since 2016. Since then, this practice area expanded to cover all matters relating to infectious diseases, and as of 2020, emergency preparedness and response (eg. WHO prequalification, International Coordination Group negotiations, Emergency Use Listing, International Health Regulations Rev 2024). He has been the pharmaceutical industry’s lead lawyer advising on the WHO Pandemic Treaty negotiations, adopted on 14 May 2025. Currently, he continues to advise on the work of the Intergovernmental Working Group (“IGWG”) teasing out the technical details of the “Pathogen Access and Benefit-Sharing System” intended to create legally binding obligations on companies to commit vaccines, therapeutics and diagnostics in case of a new global health emergency.

In Chambers rankings, clients have kindly described Bart as “very knowledgeable, action-focused and service-focused lawyer”, adding that he “really tries to find a way of working through challenges”, am “customer-oriented” and provide “sound advice and reasonable options for our business with pros and cons.”

Finally, Bart has an active pro bono practice assisting NGOs defending the human rights of persons with a disability through strategic litigation before the EU Court.